1. Home
  2. UTF vs HAE Comparison

UTF vs HAE Comparison

Compare UTF & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTF
  • HAE
  • Stock Information
  • Founded
  • UTF 2004
  • HAE 1971
  • Country
  • UTF United States
  • HAE United States
  • Employees
  • UTF N/A
  • HAE N/A
  • Industry
  • UTF Finance Companies
  • HAE Medical/Dental Instruments
  • Sector
  • UTF Finance
  • HAE Health Care
  • Exchange
  • UTF Nasdaq
  • HAE Nasdaq
  • Market Cap
  • UTF 2.3B
  • HAE 2.5B
  • IPO Year
  • UTF N/A
  • HAE 1991
  • Fundamental
  • Price
  • UTF $24.04
  • HAE $51.38
  • Analyst Decision
  • UTF
  • HAE Buy
  • Analyst Count
  • UTF 0
  • HAE 8
  • Target Price
  • UTF N/A
  • HAE $76.88
  • AVG Volume (30 Days)
  • UTF 171.7K
  • HAE 695.5K
  • Earning Date
  • UTF 01-01-0001
  • HAE 11-06-2025
  • Dividend Yield
  • UTF 7.19%
  • HAE N/A
  • EPS Growth
  • UTF N/A
  • HAE 46.89
  • EPS
  • UTF 2.84
  • HAE 3.28
  • Revenue
  • UTF $138,636,669.00
  • HAE $1,346,046,000.00
  • Revenue This Year
  • UTF N/A
  • HAE N/A
  • Revenue Next Year
  • UTF N/A
  • HAE $6.42
  • P/E Ratio
  • UTF $9.16
  • HAE $15.64
  • Revenue Growth
  • UTF 19.80
  • HAE 0.91
  • 52 Week Low
  • UTF $22.05
  • HAE $47.32
  • 52 Week High
  • UTF $26.53
  • HAE $94.99
  • Technical
  • Relative Strength Index (RSI)
  • UTF 41.88
  • HAE 51.54
  • Support Level
  • UTF $23.90
  • HAE $50.30
  • Resistance Level
  • UTF $24.23
  • HAE $51.89
  • Average True Range (ATR)
  • UTF 0.26
  • HAE 1.41
  • MACD
  • UTF 0.06
  • HAE 0.54
  • Stochastic Oscillator
  • UTF 23.73
  • HAE 81.12

About UTF Cohen & Steers Infrastructure Fund Inc

Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. It invests majority of its managed assets in securities issued by infrastructure companies, which consists of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies, under normal market conditions.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: